Atara Biotherapeutics, Inc. Business Finance Contracts & Agreements
19 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Purchase Agreements (2)
- Stock Agreements (5)
- Underwriting Agreements (8)
- Warrant Agreements (3)
- Purchase and Sale Agreement between Atara Biotherapeutics, Inc., and HCR Molag Fund, L.P., dated December 20, 2023 (Filed With SEC on February 8, 2023)
- Asset Purchase Agreement, dated as of January 26, 2022, by and between Atara Biotherapeutics, Inc., FUJIFILM Diosynth Biotechnologies California, Inc., and for certain limited... (Filed With SEC on April 4, 2022)
- Underwriting Agreement, dated as of December 8, 2020, by and among Atara Biotherapeutics, Inc., Citigroup Global Markets Inc., Evercore Group L.L.C. and Mizuho Securities USA LLC (Filed With SEC on December 9, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on December 9, 2020)
- Underwriting Agreement, dated as of May 26, 2020, by and among Atara Biotherapeutics, Inc., Citigroup Global Markets Inc., Cowen and Company, LLC and Evercore Group L.L.C (Filed With SEC on May 28, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on May 28, 2020)
- Form of Restricted Stock Unit Agreement and Restricted Stock Unit Grant Notice under the 2018 Inducement Plan (Filed With SEC on November 7, 2019)
- Underwriting Agreement, dated as of July 18, 2019, by and among Atara Biotherapeutics, Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Cowen and Company, LLC (Filed With SEC on July 22, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on July 22, 2019)
- Form of Restricted Stock Unit Agreement and Restricted Stock Unit Grant Notice under the Inducement Plan (Filed With SEC on May 8, 2018)
- Form of Stock Option Agreement and Stock Option Grant Notice under the Inducement Plan (Filed With SEC on May 8, 2018)
- Underwriting Agreement, dated as of February 28, 2018, by and among Atara Biotherapeutics, Inc., J.P. Morgan Securities LLC and Cowen and Company, LLC (Filed With SEC on March 2, 2018)
- Underwriting Agreement, dated as of January 3, 2018, by and among Atara Biotherapeutics, Inc., J.P. Morgan Securities LLC and Cowen and Company, LLC (Filed With SEC on January 4, 2018)
- Atara Biotherapeutics, Inc. Common Stock Underwriting Agreement (Filed With SEC on July 7, 2015)
- Atara Biotherapeutics, Inc. Common Stock Underwriting Agreement (Filed With SEC on February 9, 2015)
- Atara Biotherapeutics, Inc. Common Stock Underwriting Agreement (Filed With SEC on July 10, 2014)
- ATARA BIOTHERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on July 10, 2014)
- ATARA BIOTHERAPEUTICS, INC. INVESTORS RIGHTS AGREEMENT March 31, 2014 TABLE OF CONTENTS (Filed With SEC on June 20, 2014)
- ATARA BIOTHERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 20, 2014)
